CHEMOCENTRYX INC (CCXI) Stock Balance Sheet
USA - NASDAQ:CCXI - US16383L1061 - Common Stock
51.99 USD
+0.03 (+0.06%)
51.99 USD
0 (0%)
| MRQ (2022-6-30) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | 2018 (2018-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 44.40M | 49.98M | 32.30M | 39.20M | 28.10M | |||
| Marketable Securities | 284.22M | 214.51M | 404.30M | 133.60M | 148.90M | |||
| Receivables | 4.95M | 454.00K | 200.00K | 200.00K | 2.10M | |||
| Inventories | 5.47M | 851.00K | N/A | N/A | N/A | |||
| Other Current Assets | 6.14M | 3.38M | 4.80M | 1.40M | 2.30M | |||
| Total Current Assets | 345.17M | 269.18M | 441.60M | 174.40M | 181.40M | |||
| Non-Current Assets | ||||||||
| PPE Net | 55.22M | 57.08M | 52.10M | 3.90M | 1.50M | |||
| Investments And Advances | 17.55M | 97.86M | 23.80M | 29.50M | 0.00 | |||
| Other Non-Current Assets | 1.45M | 1.54M | 1.50M | 1.40M | 400.00K | |||
| Total Non-Current Assets | 74.22M | 156.47M | 77.30M | 34.70M | 1.90M | |||
| TOTAL ASSETS | 419.39M | 425.65M | 518.90M | 209.10M | 183.30M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Current Portion Of LT Debt. | 19.72M | 18.92M | 6.30M | N/A | N/A | |||
| Accrued Expenses | 27.74M | 26.36M | 19.80M | 18.70M | 12.20M | |||
| Accounts Payable | 7.59M | 6.75M | 12.90M | 1.50M | 1.00M | |||
| Other Current Liabilities | 21.02M | 10.99M | 12.60M | 38.80M | 51.30M | |||
| Total Current Liabilities | 76.08M | 63.02M | 51.60M | 59.10M | 64.40M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 4.00M | 4.71M | 18.10M | 19.80M | 19.70M | |||
| Other Non-Current Liabilities | 102.78M | 71.80M | 63.60M | 64.20M | 84.50M | |||
| Total Non-Current Liabilities | 106.78M | 76.52M | 81.70M | 84.00M | 104.20M | |||
| TOTAL LIABILITIES | 182.86M | 139.53M | 133.30M | 143.10M | 168.60M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -687.36M | -617.10M | -485.30M | -430.00M | -374.50M | |||
| Additional Paid In Capital | 926.14M | 903.65M | 870.80M | 495.60M | 389.40M | |||
| Common Shares | 71.00K | 70.00K | 100.00K | 100.00K | 100.00K | |||
| Other Shareholders' Equity | -2.33M | -499.00K | 100.00K | 300.00K | -200.00K | |||
| Shares Outstanding | 71.34M | 70.36M | 69.50M | 60.20M | 50.70M | |||
| Tangible Book Value per Share | 3.32 | 4.07 | 5.55 | 1.10 | 0.29 | |||
| Total Shareholders' Equity | 236.53M | 286.12M | 385.60M | 66.00M | 14.70M | |||
| TOTAL LIABILITIES AND EQUITY | 419.39M | 425.65M | 518.90M | 209.10M | 183.30M | |||
| Statistics | ||||||||
| Debt/Equity | 0.02 | 0.02 | 0.05 | 0.30 | 1.34 | |||
| Current Ratio | 4.54 | 4.27 | 8.56 | 2.95 | 2.82 | |||
| Return On Assets (ROA) | -31.74% | -30.95% | -10.67% | -26.54% | -20.71% | |||
| Return On Equity (ROE) | -56.27% | -46.05% | -14.36% | -84.08% | -258.30% | |||
| Return On Invested Capital (ROIC) | N/A | N/A | N/A | N/A | N/A | |||
| Return On Invested Capital Ex Cash (ROICexc) | N/A | N/A | N/A | N/A | N/A | |||
| Return On Invested Capital Ex Cash + Goodwill (ROICexcg) | N/A | N/A | N/A | N/A | N/A | |||
All data in USD , ROIC based on taxRate of 0.21